Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)Yuankai Shi, Qian Wang, Jianqiu Wu et al.|Journal of Hematology & Oncology|2021Cited by 64
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Jifeng Feng, Yongping Song et al.|BMC Cancer|2016Cited by 32
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in ChinaJianqiu Wu, Jifeng Feng, Yongping Song et al.|Chinese Medical Journal|2018Cited by 27
Artificial Bear Bile: A Novel Approach to Balancing Medical Requirements and Animal WelfareYong Li, Shishan Yu, Shaofeng Xu et al.|Engineering|2023Cited by 14